Skip to main content

Colgate-Palmolive vs Kimberly-Clark: Strategic Comparison

Direct Answer

Colgate-Palmolive is the bigger company by revenue, reporting $20.382 billion in 2025 net sales versus Kimberly-Clark's $16.447 billion from continuing operations, and Colgate also carries a larger stock market value, around $69 billion versus Kimberly-Clark's roughly $33 billion in late September 2026. Kimberly-Clark pays the bigger dividend yield, near 5.2% on its $5.12 annualized payout, compared with Colgate's roughly 2.5% yield on its $2.12 annualized payout, mainly because Kimberly-Clark's stock has lagged while it finances its pending $48.7 billion acquisition of Kenvue. On profitability, Kimberly-Clark's 2025 net margin of about 12.3% topped Colgate's 10.5%, though Colgate's margin was depressed by a one-time impairment charge.

Colgate-Palmolive and Kimberly-Clark are both Dividend Kings, but their payouts tell very different stories right now: Colgate's stock yields about 2.5% after 63 straight years of dividend increases, while Kimberly-Clark's yields roughly 5.2% after 54 straight years, a gap that reflects investor nerves over Kimberly-Clark's pending $48.7 billion purchase of Kenvue. Colgate, founded in 1806 by William Colgate in New York, is run by Chairman and CEO Noel Wallace, who became CEO in April 2019, and it reported $20.382 billion in 2025 net sales with about 33,600 employees. Kimberly-Clark, founded in 1872 in Neenah, Wisconsin, is run by Chairman and CEO Mike Hsu, who also became CEO in January 2019, and it reported $16.447 billion in FY2025 net sales from continuing operations with about 36,000 employees. Both companies are reshaping their portfolios at the same time: Colgate took a goodwill impairment on its skin health business in 2025, while Kimberly-Clark is in the middle of the largest acquisition in its history.

Editorial research by Swet Parvadiya. Figures keep each company's fiscal year; amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Sources are listed below.

Share

Key Differences at a Glance

FieldColgate-Palmolive CompanyKimberly-Clark Corporation
Latest annual revenue$20.4B (FY2025)$16.4B (FY2025)
Founded18061872
Employees33,60036,000
Market Cap$69.0B$33.0B
HeadquartersUnited StatesUnited States
Revenue / Employee$607k / employee$457k / employee
Valuation Multiple3.4x P/S2.0x P/S

Strategic Positioning

Business model and competitive context from the cited profiles

Colgate-Palmolive Company Strategic Vector

FY2025 Revenue Baseline

Colgate-Palmolive's 2025 results show the split inside the company: oral care and Hill's kept margins and cash flow strong, while the skin health push built on the 2019 Filorga deal led to an impairment that cut GAAP EPS by 25%.

Productivity: $607k / employee

Kimberly-Clark Corporation Strategic Vector

FY2025 Revenue Baseline

Kimberly-Clark Corporation's long-term commercial strategy prioritizes scaling high-margin growth vectors while actively mitigating structural industry risks. In terms of growth initiatives, management is allocating capital toward expansion of premiumization and e-commerce, where the aggressive rollout of the premiumization strategy across all consumer segments and the expansion of the e-commerce and direct-to-consumer footprint represent opportunities to increase revenue per unit and improve the company's gross margin by capturing higher margins on core categories. Concurrently, the organization focuses on navigating market pressures around intense private-label competition and declining birth rates, addressing environments where the intense and growing competitive pressure from private-label programs operated by major retail conglomerates, combined with the structural decline in global birth rates, creates a strong competitive threat that forces Kimberly-Clark to continuously innovate its branded products and invest heavily in retail trade promotions. By maintaining disciplined capital allocation and operational rigor, Kimberly-Clark Corporation aims to protect its unit economics and preserve its economic moat across changing market cycles.

Productivity: $457k / employee
Comparative Divergence: Colgate and Kimberly-Clark don't compete head-to-head on many store shelves, since Colgate leads in oral care and pet nutrition while Kimberly-Clark leads in diapers and tissue, but investors and financial media regularly pair them as rival Dividend King consumer-staples stocks alongside Procter & Gamble. That comparison sharpened in September 2026 as outlets such as 247wallst questioned whether Kimberly-Clark's 54-year dividend streak could survive the added leverage from the Kenvue deal, even as Colgate reaffirmed guidance for 2% to 6% net sales growth in 2026. Kimberly-Clark's acquisition, approved by both companies' shareholders in January 2026, is still clearing antitrust hurdles, including a European Commission review extended to October 13, 2026 and divestitures required in Australia and South Africa. Colgate, meanwhile, is still absorbing its 2025 skin health impairment while leaning on its 2022 purchase of three Red Collar Pet Foods plants to keep growing Hill's.

Colgate-Palmolive vs Kimberly-Clark Market Share

Colgate-Palmolive Company market share
Colgate-Palmolive reported a 41.3% global toothpaste market share and a 32.7% global manual toothbrush share year to date in 2026, making it the world leader in both categories.
Kimberly-Clark Corporation market share
Kimberly-Clark is one of the two largest diaper makers globally alongside Procter & Gamble and holds leading positions in facial tissue (Kleenex) and adult incontinence (Depend, Poise) in North America. It does not publish a single global market share figure.

Quick Stats Comparison

MetricColgate-Palmolive CompanyKimberly-Clark Corporation
Revenue$20.4B (FY2025)$16.4B (FY2025)
Founded18061872
HeadquartersNew York, New YorkDallas, Texas
Market Cap$69.0B$33.0B
Employees33,60036,000
Revenue / Employee$607k / employee$457k / employee
Valuation Multiple3.4x P/S2.0x P/S

Colgate-Palmolive Revenue vs Kimberly-Clark Revenue — Year by Year

YearColgate-Palmolive CompanyKimberly-Clark CorporationHigher reported revenue
2025$20.4B$16.4BColgate-Palmolive Company (approx. USD)
2024$20.1B$16.8BColgate-Palmolive Company (approx. USD)
2023$19.5B$17.1BColgate-Palmolive Company (approx. USD)
2022$18.0B$20.2BKimberly-Clark Corporation (approx. USD)
2021$17.4B$19.4BKimberly-Clark Corporation (approx. USD)

Business Model Breakdown

Overview: Colgate-Palmolive Company vs Kimberly-Clark Corporation

This in-depth comparison examines Colgate-Palmolive Company and Kimberly-Clark Corporation across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Colgate-Palmolive Company on its own, evaluating Kimberly-Clark Corporation, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Colgate-Palmolive Company and Kimberly-Clark Corporation is widest.

On the headline numbers, annual revenue is $20.4B (FY2025) for Colgate-Palmolive Company and $16.4B (FY2025) for Kimberly-Clark Corporation, while their respective market capitalizations stand at $69.0B and $33.0B. Both Colgate-Palmolive Company and Kimberly-Clark Corporation are headquartered in United States. Their local markets and applicable rules may still differ.

Colgate-Palmolive Company: Colgate-Palmolive is the world's largest toothpaste maker and one of the most international U.S. consumer staples companies. The Colgate brand is sold in more than 200 countries and territories, and in many markets the name is used as a generic word for toothpaste. Beyond oral care, it owns Palmolive, Softsoap, Irish Spring, Ajax, Fabuloso, Speed Stick and Hill's Pet Nutrition, and it has paid a dividend every year since 1895. The company is headquartered in New York City, New York.

Kimberly-Clark Corporation: Kimberly-Clark is one of the largest makers of diapers, tissue and personal care products in the world, with brands sold in about 175 countries. It is headquartered in Dallas, Texas, trades on Nasdaq under KMB, and employed about 36,000 people at the end of 2025. Its portfolio includes Huggies, Pull-Ups, GoodNites, Kleenex, Scott, Cottonelle, Viva, Kotex, U by Kotex, Depend, Poise and Andrex, plus Softex in Indonesia. The company is headquartered in Irving, Texas. The absolute massive American personal care juggernaut was founded in Wisconsin in 1872, completely inventing the modern tissue industry by repurposing WWI surgical bandages into Kotex and Kleenex.

Business Models: How Colgate-Palmolive Company and Kimberly-Clark Corporation Make Money

Colgate-Palmolive Company and Kimberly-Clark Corporation pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Colgate-Palmolive Company and Kimberly-Clark Corporation.

Colgate-Palmolive Company business model: Colgate-Palmolive sells high-frequency, repeat-purchase consumer products. Revenue comes from four categories: Oral Care (Colgate, elmex, meridol, Tom's of Maine, hello), Personal Care (Palmolive, Softsoap, Irish Spring, Protex, Sanex, Speed Stick, EltaMD, PCA Skin, Filorga), Home Care (Ajax, Fabuloso, Palmolive dish liquid, Suavitel) and Pet Nutrition (Hill's Science Diet and Hill's Prescription Diet). The company reports through five geographic Oral, Personal and Home Care segments plus Hill's. Profit depends on pricing power and premium mix: dentist and veterinarian recommendations let Colgate sell clinical toothpaste and therapeutic pet diets above private-label prices, while a long-running productivity program funds advertising. Around 70% of sales come from outside the United States.

Kimberly-Clark Corporation business model: Kimberly-Clark makes money by manufacturing and selling branded disposable hygiene and tissue products through retailers, e-commerce and distributors. Since 2024 it reports two segments: North America (consumer brands such as Huggies, Kleenex, Cottonelle, Scott, Depend and Poise, plus the North American professional business) and International Personal Care (diapers, feminine care and adult care outside North America). The International Family Care and Professional tissue business is reported as discontinued operations after being contributed to the Arbex joint venture with Suzano. Profit depends on pricing power, mix toward premium products, and productivity savings that offset pulp, resin and energy costs.

Competitive Advantage: Colgate-Palmolive Company vs Kimberly-Clark Corporation

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Colgate-Palmolive Company stack up against those of Kimberly-Clark Corporation.

Colgate-Palmolive Company competitive advantage: Colgate-Palmolive's advantage is reach plus professional endorsement. Colgate toothpaste held 41.3% global share and manual toothbrushes 32.7% year to date in 2026, built on distribution that reaches small traditional-trade shops across India, Latin America and Africa. Dentist sampling and Hill's long relationship with veterinarians give its premium products a credibility that private labels and new direct-to-consumer brands find hard to copy.

Kimberly-Clark Corporation competitive advantage: Kimberly-Clark's advantages are category-defining brands (Kleenex is used as a generic word for tissue), large-scale nonwoven and absorbent manufacturing that is expensive to replicate, long retailer relationships, and an innovation pipeline in diapers and adult care. Its productivity program has delivered gross savings that helped lift adjusted gross margin to 38.8% in Q2 2026.

Growth Strategy: Where Colgate-Palmolive Company and Kimberly-Clark Corporation Are Headed

Future prospects matter as much as current results. The growth strategies below explain how Colgate-Palmolive Company and Kimberly-Clark Corporation each plan to expand from here.

Colgate-Palmolive Company growth strategy: Colgate-Palmolive's growth plan centers on premium oral care (whitening, sensitivity, gum health and electric brushes), expanding Hill's Science Diet and Prescription Diet, and selective skin health brands such as EltaMD and PCA Skin. Productivity savings fund higher advertising, and the company has exited low-margin private-label pet food to focus Hill's on its own brands. Acquisitions are mostly bolt-ons, such as the 2022 purchase of three Red Collar Pet Foods plants for $700 million.

Kimberly-Clark Corporation growth strategy: Under its Powering Care strategy, Kimberly-Clark focuses on premium innovation (such as Huggies Skin Essentials and Depend upgrades), productivity savings, exiting low-margin businesses like US private-label diapers, and moving its international tissue business into the Arbex joint venture. It is also building an alternative natural fibers pilot plant in the US Southwest using the drought-tolerant hesperaloe plant. The Kenvue acquisition is the largest bet, adding consumer health brands to its hygiene portfolio.

Financial Picture: Colgate-Palmolive Company vs Kimberly-Clark Corporation

A closer look at the financial trajectory of Colgate-Palmolive Company and Kimberly-Clark Corporation rounds out the comparison.

Colgate-Palmolive Company: Colgate-Palmolive's revenue is steady rather than fast-growing. Net sales rose from $17.97 billion in 2022 to $20.10 billion in 2024 and $20.38 billion in 2025 (+1.4%, organic +1.4%). 2025 GAAP EPS fell 25% to $2.63 because of goodwill and intangible impairment charges tied to the skin health business (mainly Filorga), while Base Business EPS rose 3% to $3.69. Operating cash flow hit a record $4.2 billion and the company returned $2.9 billion through dividends and buybacks. In Q2 2026 net sales grew 4.9% to $5.361 billion, organic sales rose 2.4% and gross margin expanded 140 basis points to 61.5%. Colgate-Palmolive Company is a dominant multinational consumer products corporation, sustaining a market valuation typically over $70 billion.

Kimberly-Clark Corporation: FY2025 net sales from continuing operations were $16.447 billion, down 2.1% from $16.805 billion in 2024, largely reflecting exits such as US private-label diapers and currency. Gross profit was $5.923 billion, operating profit $2.351 billion and net income attributable to Kimberly-Clark $2.021 billion. In Q2 2026 net sales were $4.19 billion (up 0.6%), adjusted gross margin rose 190 basis points to 38.8%, and adjusted EPS attributable to the company was $2.12, while reported net income fell to $345 million from $509 million on deal and restructuring costs. Market value was about $33 billion in late September 2026. Kimberly-Clark Corporation is a colossal American multinational personal care corporation, commanding a market valuation typically over $45 billion.

Company-Specific SWOT Notes

Colgate-Palmolive Company

Strength

Colgate held 41.3% of global toothpaste and 32.7% of manual toothbrushes year to date in 2026, supported by dentist recommendations and deep traditional-trade distribution.

Strength

Hill's gives Colgate a premium veterinary channel, and the company generated a record $4.2 billion of operating cash flow in 2025.

Weakness

Goodwill and intangible impairment charges tied to skin health, mainly Filorga, cut 2025 GAAP EPS by 25% to $2.63.

Weakness

With roughly 70% of sales outside the U.S., currency swings in markets such as Latin America can distort reported results.

Opportunity

Whitening, sensitivity and therapeutic pet food let Colgate grow value faster than volume, helping lift Q2 2026 gross margin 140 basis points to 61.5%.

Threat

Slower category growth, weak North American demand, raw material inflation, tariffs and store brands pressure volumes and pricing.

Kimberly-Clark Corporation

Strength

Kimberly-Clark's proprietary material science and nonwoven manufacturing infrastructure combined with a global brand portfolio that includes genericized trademarks like Kleenex and Andrex creates a level of operational scale, consumer trust, and retail negotia

Strength

The Dallas-based company manufactures personal care and hygiene products that consumers purchase out of biological necessity rather than desire which is both its core competitive advantage and its defining strategic constraint: need-based consumption is recess

Weakness

The company's reliance on fluff pulp, superabsorbent polymers, and polyethylene resins creates a fundamental vulnerability to raw material price volatility, meaning that any mismatch between raw material cost inflation and retail pricing power directly compres

Weakness

FY2025 net sales from continuing operations were $16.447 billion, down 2.1% from $16.805 billion in 2024, largely reflecting exits such as US private-label diapers and currency.

Opportunity

The aggressive rollout of the premiumization strategy across all consumer segments and the expansion of the e-commerce and direct-to-consumer footprint represent opportunities to increase revenue per unit and improve the company's gross margin by capturing hig

Threat

The intense and growing competitive pressure from private-label programs operated by major retail conglomerates, combined with the structural decline in global birth rates, creates a strong competitive threat that forces Kimberly-Clark to continuously innovate

Factual Scorecard

CategoryResultWhy
Same-period Revenue ScaleColgate-Palmolive Company$20.4B (FY2025) versus $16.4B (FY2025); the higher figure is identified after approximate USD conversion.
Founded EarlierColgate-Palmolive CompanyColgate-Palmolive Company was founded in 1806; Kimberly-Clark Corporation was founded in 1872.
Verdict

Comparison Takeaway: Colgate-Palmolive vs Kimberly-Clark

Colgate and Kimberly-Clark reach Dividend King status by different routes. Colgate grows mainly through pricing power and premium mix in oral care, where it holds a 41.3% global toothpaste share, plus expansion of Hill's Pet Nutrition, which helped push operating cash flow to a record $4.2 billion in 2025 even after a 25% drop in GAAP EPS to $2.63 from a skin health impairment. Kimberly-Clark grows more slowly on its own, with FY2025 net sales down 2.1% as it exited lower-margin lines such as US private-label diapers, and is instead betting on scale: closing the $48.7 billion Kenvue deal would roughly double its revenue base to about $32 billion and move it into consumer health alongside Tylenol and Listerine. Colgate's underlying earnings are steadier, with Base Business EPS up 3% to $3.69 in 2025, while Kimberly-Clark's reported net income fell to $345 million in Q2 2026 from $509 million a year earlier on deal and restructuring costs. For now, Colgate looks like the lower-risk compounder and Kimberly-Clark the higher-yield, higher-uncertainty transformation story.

Methodology and sourcing reviewed by Swet Parvadiya. No date is shown unless this comparison has its own editorial review date.

Frequently Asked Questions: Colgate-Palmolive vs Kimberly-Clark

Is Colgate-Palmolive bigger than Kimberly-Clark?

Yes, by revenue. Colgate-Palmolive reported $20.382 billion in 2025 net sales, about 24% more than Kimberly-Clark's $16.447 billion in FY2025 net sales from continuing operations. Colgate is also the larger company by stock market value, worth roughly $69 billion versus Kimberly-Clark's approximately $33 billion as of late September 2026.

Which stock pays a higher dividend yield, Colgate-Palmolive or Kimberly-Clark?

Kimberly-Clark pays the higher yield, about 5.2% on its $5.12 annualized dividend as of September 2026, versus roughly 2.5% for Colgate-Palmolive's $2.12 annualized dividend. The gap exists because Kimberly-Clark's shares have traded lower while it finances its pending $48.7 billion acquisition of Kenvue, even though Colgate holds the longer dividend-growth streak at 63 consecutive years versus Kimberly-Clark's 54.

Who runs Colgate-Palmolive and Kimberly-Clark?

Noel Wallace is Chairman, President and CEO of Colgate-Palmolive, a role he has held since becoming CEO in April 2019 and chairman in 2020. Mike Hsu is Chairman and CEO of Kimberly-Clark, having become CEO in January 2019 and chairman in 2020, and he is now also leading Kimberly-Clark's pending acquisition of Kenvue.

Why is Kimberly-Clark buying Kenvue?

Kimberly-Clark agreed in November 2025 to acquire Kenvue, owner of Tylenol, Band-Aid, Listerine, Neutrogena and Aveeno, in a deal valued at about $48.7 billion. The combination, expected to close in the fourth quarter of 2026, would create a company with roughly $32 billion of 2025 revenue, nearly double Kimberly-Clark's standalone net sales and well above Colgate-Palmolive's $20.382 billion.

Which is the better dividend stock, Colgate-Palmolive or Kimberly-Clark?

It depends on the investor's priority. Colgate-Palmolive offers steadier underlying growth, with Base Business EPS up 3% to $3.69 in 2025 and a 63-year dividend-increase streak, while Kimberly-Clark offers a much higher current yield near 5.2% but carries more near-term risk from financing its $48.7 billion Kenvue acquisition. Neither company's 2025 net income tells the full story: Colgate's GAAP EPS fell 25% on an impairment charge, and Kimberly-Clark's Q2 2026 net income dropped on deal costs, so investors should weigh each company's adjusted earnings rather than headline GAAP figures.

Which company was founded first, Colgate-Palmolive Company or Kimberly-Clark Corporation?

Colgate-Palmolive Company was founded in 1806; Kimberly-Clark Corporation was founded in 1872.

What revenue did Colgate-Palmolive Company and Kimberly-Clark Corporation report?

Colgate-Palmolive Company had $20.4B (FY2025), while Kimberly-Clark Corporation had $16.4B (FY2025). These figures describe revenue scale; they do not by themselves determine an overall winner.

How do Colgate-Palmolive Company and Kimberly-Clark Corporation make money?

Colgate-Palmolive Company: Colgate-Palmolive sells high-frequency, repeat-purchase consumer products. Kimberly-Clark Corporation: Kimberly-Clark makes money by manufacturing and selling branded disposable hygiene and tissue products through retailers, e-commerce and distributors.

Which is better, Colgate-Palmolive Company or Kimberly-Clark Corporation?

There is no evidence-based single winner. Compare Colgate-Palmolive Company and Kimberly-Clark Corporation on the same fiscal period and the metric relevant to the question, such as revenue, profitability, growth, product fit, or market value.

Sources & References

Quick Answer

Colgate-Palmolive is the bigger company by revenue, reporting $20.382 billion in 2025 net sales versus Kimberly-Clark's $16.447 billion from continuing operations, and Colgate also carries a larger stock market value, around $69 billion versus Kimberly-Clark's roughly $33 billion in late September 2026. Kimberly-Clark pays the bigger dividend yield, near 5.2% on its $5.12 annualized payout, compared with Colgate's roughly 2.5% yield on its $2.12 annualized payout, mainly because Kimberly-Clark's stock has lagged while it finances its pending $48.7 billion acquisition of Kenvue. On profitability, Kimberly-Clark's 2025 net margin of about 12.3% topped Colgate's 10.5%, though Colgate's margin was depressed by a one-time impairment charge.

Verdict

Colgate and Kimberly-Clark reach Dividend King status by different routes. Colgate grows mainly through pricing power and premium mix in oral care, where it holds a 41.3% global toothpaste share, plus expansion of Hill's Pet Nutrition, which helped push operating cash flow to a record $4.2 billion in 2025 even after a 25% drop in GAAP EPS to $2.63 from a skin health impairment. Kimberly-Clark grows more slowly on its own, with FY2025 net sales down 2.1% as it exited lower-margin lines such as US private-label diapers, and is instead betting on scale: closing the $48.7 billion Kenvue deal would roughly double its revenue base to about $32 billion and move it into consumer health alongside Tylenol and Listerine. Colgate's underlying earnings are steadier, with Base Business EPS up 3% to $3.69 in 2025, while Kimberly-Clark's reported net income fell to $345 million in Q2 2026 from $509 million a year earlier on deal and restructuring costs. For now, Colgate looks like the lower-risk compounder and Kimberly-Clark the higher-yield, higher-uncertainty transformation story.

Cite This Page

Automatically generated citations for researchers.

APA Format

CorpDigest. (2026). Colgate-Palmolive Company vs Kimberly-Clark Corporation Comparison. from https://corpdigest.com/compare/colgate-palmolive-vs-kimberly-clark

MLA Format

CorpDigest. "Colgate-Palmolive Company vs Kimberly-Clark Corporation Comparison." CorpDigest, 2026, https://corpdigest.com/compare/colgate-palmolive-vs-kimberly-clark.

Chicago Format

CorpDigest. "Colgate-Palmolive Company vs Kimberly-Clark Corporation Comparison." CorpDigest. 2026. https://corpdigest.com/compare/colgate-palmolive-vs-kimberly-clark.

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.